Workflow
Volition(VNRX) - 2022 Q1 - Earnings Call Transcript

VolitionRx Limited (NYSE:VNRX) Q1 2022 Results Conference Call May 12, 2022 8:30 AM ET Company Participants Scott Powell - Executive Vice President of Investor Relations Cameron Reynolds - President and Chief Executive Officer Tom Butera - Chief Executive Officer, Volition Veterinary Diagnostics Development Terig Hughes - Chief Financial Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald Operator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited's ...